Safety and efficacy of REP 2139-Mg in hepatitis D patients: reporting of extended follow-up data from the international compassionate use program

Conference Reports for NATAP

The Liver Meeting
AASLD 2024
Nov 15-19,
San Diego, CA


Safety and efficacy of REP 2139-Mg in hepatitis D patients: reporting of extended follow-up data from the international compassionate use program

	AASLD 2024 Nov 15-19 San Diego